News

Click a news item to be directed to the full story. Send your news to bioohio@bioohio.com.

Found 5500 Results

OSU center gets $7.5M grant to combat nerve agents

Under a $7.5 million NIH grant, Ohio State University chemists will collaborate with the U.S. Army Medical Research Institute of Chemical Defense and Israel’s Weizmann Institute of Science to harness the body’s own defenses to counteract nerve agents that might be used in terrorist attacks. The research could also one day lead to new types […]

November 16, 2011

Ohio at forefront of combining biomedical research with electronic patient data

A recent National Research Council (NRC) report proposes a data network that integrates emerging molecular research with patient clinical data to more accurately classify diseases and ultimately enhance diagnosis and treatment. “Currently, a disconnect exists between the wealth of scientific advances in research and the incorporation of this information into the clinic,” said Susan Desmond-Hellmann, co-chair […]

November 14, 2011

2011 BioOhio Annual Conference in 2 minutes

We had such a good time at our October 27 Annual Conference that we made a movie about it. Sort of. Actually, we wanted to do a video retrospective to capture the energy and insight the event always brings (and to shamelessly plug the annual conference franchise). We’re lucky to have a member company, BioMedia, […]

November 10, 2011

State launches new tax credit program to spur small business investment

The Ohio Department of Development, in collaboration with the Department of Taxation, has released details on InvestOhio, the highly-anticipated $100 million effort to spur investments in Ohio’s small businesses. The program is expected to generate at least $1 billion in new private investment in Ohio small businesses by 2013.

November 10, 2011

Another spine device company coming to northeast Ohio?

MedCity News’ Brandon Glenn reports today that Lousville, Kentucky’s OrthoData is looking to relocate to the Cleveland area (read article here). OrthoData CEO Ric Navarro is a Northeast Ohio native who was previously an executive with Integra Spine in Medina. If the relocation happens, OrthoData will join the growing ranks of spinal device companies in […]

November 9, 2011

Ausio Pharmaceuticals signs license agreement with San Diego oncology company

Cincinnati-based Ausio Pharmaceuticals has signed an exclusive, royalty-bearing license agreement with Marshall Edwards, Inc., an oncology company focused on novel therapeutics targeting cancer metabolism. The agreement gives Ausio exclusive, worldwide rights under certain Marshall Edwards patents to develop, manufacture and sell products utilizing equol, a nonsteroidal estrogen, for non-oncology applications. In exchange, Marshall Edwards will receive […]

November 8, 2011

Two Mentor companies launch products

The biomedical market got an extra dose of Mentor, Ohio, last week, when both US Endoscopy and STERIS Corporation introduced new products. US Endoscopy announced the full market release of their Infinity sampling device. This device is purpose-built for collecting substantial and quality samples from strictures in the biliary duct during ERCP (endoscopic retrograde cholangiopancreatography) procedures. […]

November 4, 2011

Number of bioscience graduates in Ohio on the rise

November 3, 2011 | micrOHscope.com

Number of bioscience graduates in Ohio on the rise

Ohio has 478 post-secondary institutions serving all industries and walks of life, from universities and community colleges to specialized job training centers and vocational schools. Many of these schools offer bioscience-related courses and degrees. In FY2010, Ohio institutions awarded 8,088 bioscience related degrees, up 395 from the previous year (7,693). Comparing 2010 to 2006, the […]

November 2, 2011

AtriCure’s ablation system receives ‘vote of approval’ from FDA expert advisors

West Chester-based AtriCure, Inc. (Nasdaq: ATRC) announced that their Synergy Ablation System received a vote of approval from the Circulatory System Devices Panel of the U.S. Food and Drug Administration (FDA). The panel recommended that the FDA approve the system for the treatment of atrial fibrillation (AF) during open-heart concomitant surgical procedures. This marks the […]

October 31, 2011